ArticleActive
Response to Comments: MolDX: DecisionDx-Melanoma
A56230
Effective: February 10, 2019
Updated: December 31, 2025
Policy Summary
This policy record (A56230) is an administrative Response to Comments for MolDX: DecisionDx-Melanoma and does not contain clinical coverage, indication, limitation, or frequency criteria. It documents the comment period (06/07/2018–08/14/2018), notice period (12/26/2018–02/09/2019), and the LCD finalization date (02/10/2019); clinical coverage details are expected in the referenced LCD DL37750 and should be reviewed separately.
Coverage Criteria Preview
Key requirements from the full policy
"This document is an administrative response to comments and does not specify clinical coverage criteria; it records the comment period (06/07/2018–08/14/2018), notice period (12/26/2018–02/09/2019)..."
Sign up to see full coverage criteria, indications, and limitations.